查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1776195

經顱都卜勒超音波的全球市場:洞察，競爭情形，市場預測:2032年

Transcranial Doppler - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計在2025年至2032年的預測期內，經顱多普勒市場將以5.89%的複合年增長率成長。創傷性腦損傷 (TBI) 的增加、中風和腦血管痙攣等神經系統疾病盛行率的上升以及運動相關損傷的急劇增加，顯著推動了全球對經顱多普勒設備的需求。這些疾病需要持續、即時監測腦血流，而這正是經顱多普勒設備的主要用途。此外，領先的市場參與者在研發和產品開發方面不斷投入，催生了先進、便攜、整合人工智慧的經顱多普勒系統，使這項技術在各種臨床環境中更易於獲取和有效應用。這些因素共同推動了經顱多普勒市場的普及和成長，預計將在2025年至2032年的預測期內推動市場成長。

經顱多普勒市場動態：

根據國際腦損傷協會的數據，歐盟每年約有100萬人因腦損傷住院。其中，機車事故佔創傷性腦損傷(TBI)的50%。此外，運動相關的腦損傷也是造成這數字的重要原因，估計每年有30萬人受傷。冬季運動，尤其是滑雪和冰上訓練，與其中約2萬人的腦損傷有關。日益加重的腦損傷負擔推動了對先進即時診斷工具的需求。經顱多普勒超音波因其能夠非侵入性地評估腦血流並檢測血管併發症，越來越多地被用於創傷性腦損傷的急性和長期管理。這種日益增長的臨床需求推動了經顱多普勒超音波市場的穩定成長。

根據世界衛生組織 (WHO) (2023) 的數據，到 2023 年，全球將有超過 180 萬人患有多發性硬化症 (MS)。 MS 是一種影響大腦和脊髓功能的慢性免疫介導疾病。隨著早期發現和監測血管問題變得至關重要，經顱多普勒超音波在非侵入性評估腦血流方面的重要性日益凸顯。人們對 MS 的認識和診斷不斷提高，推動了對先進神經診斷工具的需求，並促進了經顱多普勒超音波市場的發展。

此外，根據世界衛生組織 (WHO) (2024) 的數據，全球約有 5,000 萬人患有癲癇，使其成為全球最常見的神經系統疾病之一。值得注意的是，近 80% 的癲癇患者生活在中低收入國家，這些國家獲得適當診斷和治療設施的機會仍然有限。據估計，透過準確的診斷和及時治療，高達 70% 的癲癇患者可以實現無癲癇發作的生活。此外，全球每年報告約 500 萬例新癲癇病例。這一沉重的疾病負擔凸顯了對便捷、非侵入性診斷工具日益增長的需求。經顱多普勒可以即時評估腦血流，並有助於識別與癲癇發作相關的血管異常。隨著人們對癲癇的認識和醫療保健基礎設施的不斷提高，尤其是在醫療資源匱乏的地區，癲癇盛行率的上升預計將顯著推動對經顱多普勒的需求。

因此，預計所有上述因素將在2025年至2032年的預測期內共同推動經顱多普勒市場的發展。

然而，嚴格的監管審批以及市場上替代方案的可用性等因素可能會抑制經顱多普勒市場的成長。

經顱多普勒市場細分分析：

經顱多普勒市場：產品類型（可攜式、獨立式、穿戴式）、操作模式（手動、自動）、最終用戶（醫院、門診手術中心、其他）、地區（北美、歐洲、亞太地區、其他）

在經顱多普勒市場的操作模式細分中，自動化類別預計將在2024年佔據最大的市場收入佔有率。這項優勢源自於自動化多普勒系統的優勢，它能夠提高診斷準確性、減少對操作員的依賴並簡化臨床工作流程。與手動系統不同，自動化經顱多普勒結合了人工智慧驅動的演算法和機器人輔助探頭，能夠以最少的使用者輸入即時監測腦血流。這些系統提供標準化的數據解釋，顯著降低了由於操作員專業知識而導致的差異，並擴大了非專業人員和資源有限環境下的可及性。主要功能包括自動血管檢測、即時波形分析以及基於雲端的資料集成，可用於遠端存取和遠距醫療應用。

飛利浦的 D2tcd 探頭提供自動化、非影像的 TCD 功能，並結合人工智慧技術，可識別血管並持續監測腦血流動力學。事實證明，此類技術創新在準確性和一致性至關重要的領域尤其有用，例如中風評估、創傷性腦損傷管理、神經重症監護和術中監測。遠距醫療解決方案以及與醫院資訊系統無縫整合的需求日益增長，進一步加速了自動化 TCD 系統的普及。

因此，預計自動化產業將在2025年至2032年期間經歷顯著成長，並對整個經顱多普勒市場的擴張做出重大貢獻。

預計北美將主導整個經顱多普勒市場：

在所有地區中，預計北美將在2024年佔據經顱多普勒市場的最大佔有率。這可能是由於創傷性腦損傷發病率的上升、帕金森氏症患者的不斷增長、產品開發和監管審批的重大進展，以及該地區主要市場參與者的存在。預計這些因素將推動經顱多普勒市場在2025年至2032年期間持續擴張和創新。

根據美國疾病管制與預防中心（2024年）的數據，美國每天有超過586例因創傷性腦損傷（TBI）住院治療。 TBI通常由事故、跌倒、運動傷害等造成的頭部創傷引起，需要快速且準確的診斷以評估腦損傷程度並確定治療方案。此類損傷通常會導致骨折，需要手術介入和固定才能確保骨折完全癒合。損傷數量的增加推動了對快速、非侵入性診斷工具的需求，例如經顱多普勒超音波，它可以評估腦血流並確定腦損傷的嚴重程度。因此，TBI負擔的加重已成為推動經顱多普勒市場成長的關鍵因素。

根據帕金森基金會 (2024) 的數據，到 2023 年，美國將有近 100 萬人患有帕金森氏症，預計到 2030 年這一數字將增至 120 萬。帕金森氏症是繼阿茲海默症之後第二常見的神經退化性疾病，在老年人口中發病率持續上升，美國每年約有 9 萬例新診斷病例。經顱多普勒超音波檢查可以非侵入性地評估腦血流，越來越多地用於檢測血管異常並監測神經退化性疾病患者的腦血流動態。因此，帕金森病患病率的上升極大地促進了經顱多普勒超音波檢查市場的擴張。

此外，西門子醫療私人有限公司和佳能醫療系統公司等主要市場參與者的強大銷售網絡確保了這些設備在整個地區的廣泛可用性和可及性，擴大了其市場收入佔有率並在該地區站穩了腳跟，刺激了技術創新和市場增長。

因此，所有上述因素將在2025年至2032年的預測期內為經顱多普勒市場營造有利的環境。

經顱多普勒市場的主要公司

經顱多普勒市場的主要市場參與者包括Atys Medical、Compumedics Limited、NeuraSignal, Inc.、Recorders &Medicare Systems Pvt。 (RMS)、Rimed Ltd.、深圳德利卡醫療設備有限公司、Viasonix.、NeuraSignal, Inc.、柯尼卡美能達醫療印度私人有限公司、通用電氣醫療集團、荷蘭皇家飛利浦公司、邁瑞、富士膠片索諾聲公司、西門子醫療私人有限公司和佳能醫療系統公司。

經顱多普勒市場的最新發展：

  • 2024年5月，加州大學聖地牙哥分校的工程師開發了一種穿戴式超音波貼片，用於非侵入性、持續監測腦血流。這款柔軟、可拉伸的貼片設計用於佩戴在太陽穴上，可提供腦血流的三維數據。穿戴式超音波貼片代表了目前臨床標準經顱多普勒超音波的重大飛躍。

經顱多普勒市場報告重點

  • 目前經顱多普勒市場規模分析（2024 年）及 8 年市場預測（2025-2032 年）
  • 過去三年主要產品/服務開發、合併、收購、合作及合資企業
  • 主導經顱多普勒市場的主要公司
  • 經顱多普勒市場中競爭對手面臨的各種機會
  • 2024 年各細分市場的領先產業及其 2032 年的表現
  • 目前經顱多普勒市場中排名靠前的地區和國家
  • 未來經顱多普勒市場成長機會中企業應重點關注的地區和國家

關於經顱多普勒的常見問題多普勒市場

1. 經顱多普勒

  • 經顱多普勒是一種非侵入性超音波技術，用於測量主要腦動脈的血流速度。它提供即時血流動力學數據，可用於各種臨床環境。

    2. 經顱多普勒市場

    • 預計在 2025 年至 2032 年的預測期內，經顱多普勒市場將以 5.89% 的複合年增長率成長。

    3.經顱多普勒市場驅動因子

    • 創傷性腦損傷 (TBI) 的增加、中風和腦血管痙攣等神經系統疾病的盛行率上升以及運動相關損傷的急劇增加，極大地推動了全球對經顱多普勒設備的需求。這些情況需要持續、即時監測腦血流，而這正是經顱多普勒設備的主要應用。此外，市場領先的公司正在大力投資研發和產品開發，從而推動了先進、便攜且整合人工智慧的經顱多普勒設備的開發。經顱多普勒系統的推出使得這項技術在各種臨床環境中更加普及且更有效。這些因素共同推動了經顱多普勒市場的普及和成長，並預計在2025年至2032年的預測期內推動市場發展。

    4.開展經顱都卜勒超音波市場上事業的主要企業有哪些？

    • 進入到經顱都卜勒超音波市場的主要打入市場企業有Compumedics Limited，NeuraSignal, Inc.，Recorders &Medicare Systems Pvt Ltd(RMS)，Rimed Ltd.，深圳 Delica Medical Equipment Co，Viasonix，NeuraSignal, Inc.，Konica Minolta Healthcare India Private Limited，GE HealthCare，Koninklijke Philips N.V.，Mindray，FUJIFILM Sonosite, Inc.，Siemens Healthcare Private Limited，CANON MEDICAL SYSTEMS 有CORPORATION等。

    5. 經顱多普勒市佔率最大的地區

    • 在所有地區中，預計北美將在2024年佔據經顱多普勒市場的最大收入佔有率。這可能是由於創傷性腦損傷盛行率的上升、帕金森氏症患者的成長、產品開發和監管審批的顯著進展，以及該地區主要市場參與者的重大貢獻。預計這些綜合因素將在2025年至2032年期間推動經顱多普勒市場持續擴張和創新。

    目錄

    第1章 經顱都卜勒超音波市場報告的簡介

    第2章 經顱都卜勒超音波市場摘要整理

    第3章 競爭情形

    第4章 法規分析

    • 美國
    • 歐洲
    • 日本
    • 中國

    第5章 經顱都卜勒超音波市場主要原因分析

    • 經顱多普勒市場推動因素
      • 腦外傷發生率上升損傷
      • 神經系統疾病盛行率不斷上升
      • 運動相關傷害不斷增加
    • 經顱多普勒市場的限制與挑戰
      • 嚴格的監管審批
      • 市場上替代方案的可用性
    • 經顱多普勒市場機遇
      • 經顱多普勒監測設備中人工智慧 (AI) 與雲端平台的集成

    第6章 經顱都卜勒超音波市場波特的五力分析

    第7章 經顱都卜勒超音波市場評估

    • 各產品類型
      • 可攜式
      • 獨立的
      • 穿戴式
    • 行動模式別
      • 手動
      • 自動
    • 各終端用戶
      • 醫院
      • 門診病人手術中心
      • 其他
    • 地區
      • 北美
      • 歐洲
      • 亞太地區
      • 其他地區

    第8章 經顱都卜勒超音波市場企業與產品簡介

    • Atys Medical
    • Compumedics Limited
    • NeuraSignal, Inc.
    • Recorders & Medicare Systems Pvt Ltd (RMS)
    • Rimed Ltd.
    • Shenzhen Delica Medical Equipment Co., Ltd.
    • Viasonix.
    • NeuraSignal, Inc.
    • Konica Minolta Healthcare India Private Limited
    • GE HealthCare
    • Koninklijke Philips N.V.
    • Mindray
    • FUJIFILM Sonosite, Inc.
    • Siemens Healthcare Private Limited
    • CANON MEDICAL SYSTEMS CORPORATION

    第9章 KOL的見解

    第10章 計劃方法

    第11章 關於DelveInsight

    第12章 免責聲明和諮詢方式

Product Code: DIMDCL0245

Transcranial Doppler Market by Product Type (Portable, Stand-alone, and Wearable), Mode of Operation (Manual and Automated), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing incidence of traumatic brain injuries, rising prevalence of neurological disorders, and increasing sport related injuries.

The transcranial doppler market is estimated to grow at a CAGR of 5.89% during the forecast period from 2025 to 2032. The increasing instances of traumatic brain injuries (TBI), rising prevalence of neurological disorders such as stroke and cerebral vasospasm, and the surge in sport-related injuries are significantly boosting the demand for transcranial doppler devices globally. These conditions require continuous and real-time monitoring of cerebral blood flow, a key application of transcranial doppler devices. Additionally, growing investments in R&D and product development by key market players have led to the launch of advanced, portable, and AI-integrated transcranial doppler devices systems, making the technology more accessible and effective across diverse clinical settings. Collectively, these factors are driving the widespread adoption and growth of the transcranial doppler market, that are expected to drive the transcranial doppler market during the forecast period from 2025 to 2032.

Transcranial Doppler Market Dynamics:

According to the International Brain Injury Association (2025), brain injuries resulted in approximately one million hospital admissions annually within the European Union. Among these, motor vehicle crashes were responsible for 50% of traumatic brain injuries (TBIs). Additionally, sports-related brain injuries contributed significantly to this figure, with an estimated 300,000 injuries occurring each year. Winter sports, particularly skiing and ice-skating, were linked to around 20,000 of these brain injuries. The growing burden of brain injuries is driving demand for advanced, real-time diagnostic tools. Transcranial Doppler, with its ability to non-invasively assess cerebral blood flow and detect vascular complications, is increasingly being adopted in the acute and long-term management of traumatic brain injuries. This rising clinical need is contributing to the steady growth of the transcranial doppler market.

According to the World Health Organization (2023), over 1.8 million people worldwide were living with multiple sclerosis (MS) in 2023. Multiple sclerosis (MS) is a chronic, immune-mediated disorder affecting brain and spinal cord functions. As early detection and monitoring of vascular issues become essential, transcranial Doppler ultrasound is gaining importance for its non-invasive assessment of cerebral blood flow. Growing awareness and diagnosis of MS are driving demand for advanced neurodiagnostic tools, boosting the transcranial doppler market.

Moreover, according to the World Health Organization (2024), approximately 50 million people worldwide were living with epilepsy, making it one of the most prevalent neurological disorders globally. Notably, nearly 80% of individuals with epilepsy reside in low- and middle-income countries, where access to proper diagnostic and treatment facilities remains limited. It was estimated that up to 70% of people with epilepsy could achieve seizure-free lives with accurate diagnosis and timely treatment. Furthermore, around 5 million new cases of epilepsy are reported globally each year. This substantial disease burden highlights the growing need for accessible, non-invasive diagnostic tools. Transcranial doppler, which enables real-time assessment of cerebral blood flow and can aid in identifying vascular abnormalities associated with seizure activity, is emerging as a valuable tool in both diagnosis and monitoring. As awareness and healthcare infrastructure improve, especially in underserved regions, the increasing prevalence of epilepsy is expected to significantly drive demand for transcranial doppler.

Hence, the interplay of all the above-mentioned factors is expected to drive the market of transcranial doppler market during the given forecast period from 2025 to 2032.

However, the stringent regulatory approvals and availability of alternative options in the market, among others, may restrain the growth of the transcranial doppler market.

Transcranial Doppler Market Segment Analysis:

Transcranial Doppler Market by Product Type (Portable, Stand-alone, and Wearable), Mode of Operation (Manual and Automated), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the mode of operation segment of the transcranial doppler market, the automated category is projected to hold the largest share of market revenue in 2024. This dominance is driven by the advantages of automated doppler systems, which enhance diagnostic accuracy, reduce operator dependency, and streamline clinical workflows. Unlike manual systems, automated transcranial dopplers incorporate AI-driven algorithms and robotic-assisted probes to enable real-time monitoring of cerebral blood flow with minimal user input. These systems deliver standardized data interpretation, significantly reducing variability due to operator expertise and expanding accessibility in non-specialist and resource-limited settings. Key features include automated vessel detection, real-time waveform analysis, and cloud-based data integration for remote access and telemedicine applications.

One notable example is the Philips D2tcd transducer, which offers automated, non-imaging TCD capabilities with AI support for vessel identification and continuous cerebral hemodynamic monitoring. Such innovations are proving especially valuable in stroke assessment, traumatic brain injury management, neurocritical care, and intraoperative monitoring, areas where accuracy and consistency are critical. The increasing demand for telehealth-compatible solutions and seamless integration with hospital information systems has further accelerated the adoption of automated TCD systems.

As a result, the automated segment is expected to experience significant growth, substantially contributing to the overall expansion of the transcranial doppler market from 2025 to 2032.

North America is expected to dominate the overall transcranial doppler market:

Among all the regions, North America is expected to amass the largest share of the transcranial doppler market in 2024. This can be ascribed to the rising incidence of traumatic brain injuries, growing population with Parkinson's disease, significant advancements in product development & regulatory approvals, and the presence of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the transcranial doppler market from 2025 to 2032.

According to data from the Centers for Disease Control and Prevention (2024), the United States experiences over 586 traumatic brain injury (TBI)-related hospitalizations each day. TBIs, often resulting from head trauma due to accidents, falls, or sports injuries, require prompt and accurate diagnosis to assess the extent of brain damage and inform treatment decisions. These injuries frequently lead to fractures that necessitate surgical intervention and stabilization to ensure proper healing. The growing instances of such trauma have heightened the need for rapid, non-invasive diagnostic tools such as transcranial doppler ultrasound, which can evaluate cerebral blood flow and determine the severity of brain injury. As a result, the increasing burden of TBIs is emerging as a major factor driving the growth of the transcranial doppler market.

According to the Parkinson's Foundation (2024), nearly one million individuals in the United States were living with Parkinson's disease in 2023, with the number projected to rise to 1.2 million by 2030. As the second-most common neurodegenerative disorder after Alzheimer's disease, Parkinson's continues to affect a growing segment of the aging population, with approximately 90,000 new cases diagnosed annually in the U.S. This rising prevalence underscores the urgent need for effective diagnostic and monitoring tools. Transcranial doppler, which enables non-invasive assessment of cerebral blood flow, is increasingly being utilized to detect vascular abnormalities and monitor cerebral hemodynamics in patients with neurodegenerative conditions. As a result, the growing incidence of parkinson's disease is contributing significantly to the expansion of the transcranial doppler market.

Moreover, the presence of key market players such as Siemens Healthcare Private Limited and CANON MEDICAL SYSTEMS CORPORATION, with their strong distribution networks, ensures widespread availability and accessibility of these devices across the region, increasing their revenue shares in the market have establishing strong footholds in the region, driving innovation and market growth.

Thus, all the factors mentioned above promote a conducive environment for the transcranial doppler market during the forecast period from 2025 to 2032.

Transcranial Doppler Market Key Players:

Some of the key market players operating in the transcranial doppler market include Atys Medical, Compumedics Limited, NeuraSignal, Inc., Recorders & Medicare Systems Pvt Ltd. (RMS), Rimed Ltd., Shenzhen Delica Medical Equipment Co., Ltd., Viasonix., NeuraSignal, Inc., Konica Minolta Healthcare India Private Limited, GE HealthCare, Koninklijke Philips N.V., Mindray, FUJIFILM Sonosite, Inc., Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, and others.

Recent Developmental Activities in the Transcranial Doppler Market:

  • In May 2024, Engineers at the University of California, San Diego developed a wearable ultrasound patch capable of providing continuous, non-invasive monitoring of blood flow in the brain. The soft and stretchy patch was designed to be worn on the temple, offering three-dimensional data on cerebral blood flow, marking a first in wearable technology. The wearable ultrasound patch marks a significant leap from the current clinical standard, called transcranial Doppler ultrasound.

Key takeaways from the transcranial doppler market report study

  • Market size analysis for current transcranial doppler market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the transcranial doppler market
  • Various opportunities available for the other competitors in the transcranial doppler market space
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current transcranial doppler market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for transcranial doppler market growth in the coming future?

Target audience who can benefit from this transcranial doppler market report study

  • Transcranial Doppler providers
  • Research organizations and consulting companies
  • Transcranial doppler related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in transcranial doppler
  • Various end-users who want to know more about the transcranial doppler market and the latest developments in the transcranial doppler market

Frequently Asked Questions for the Transcranial Doppler Market:

1. What are transcranial doppler?

  • The transcranial doppler is a non-invasive ultrasound technique used to measure blood flow velocity in the major cerebral arteries. It provides real-time data on hemodynamics, making it valuable in various clinical settings.

2. What is the market for transcranial doppler?

  • The transcranial doppler market is estimated to grow at a CAGR of 5.89% during the forecast period from 2025 to 2032.

3. What are the drivers for the transcranial doppler market?

  • The increasing instances of traumatic brain injuries (TBI), rising prevalence of neurological disorders such as stroke and cerebral vasospasm, and the surge in sport-related injuries are significantly boosting the demand for transcranial doppler devices globally. These conditions require continuous and real-time monitoring of cerebral blood flow, a key application of transcranial doppler devices. Additionally, growing investments in R&D and product development by key market players have led to the launch of advanced, portable, and AI-integrated transcranial doppler systems, making the technology more accessible and effective across diverse clinical settings. Collectively, these factors are driving the widespread adoption and growth of the transcranial doppler market, that are expected to drive the transcranial doppler market during the forecast period from 2025 to 2032.

4. Who are the key players operating in the transcranial doppler market?

  • Some of the key market players operating in the transcranial doppler market include Compumedics Limited, NeuraSignal, Inc., Recorders & Medicare Systems Pvt Ltd (RMS), Rimed Ltd., Shenzhen Delica Medical Equipment Co., Ltd., Viasonix, NeuraSignal, Inc., Konica Minolta Healthcare India Private Limited, GE HealthCare, Koninklijke Philips N.V., Mindray, FUJIFILM Sonosite, Inc., Siemens Healthcare Private Limited, CANON MEDICAL SYSTEMS CORPORATION, and others.

5. Which region has the highest share in the transcranial doppler market?

  • Among all the regions, North America is estimated to hold a significant revenue share in the transcranial doppler market in 2024. This can be ascribed to the rising incidence of traumatic brain injuries, growing population with parkinson's disease, significant advancements in product development & regulatory approvals, and the significant contributions of key market players in the region. The combination of these factors is expected to drive the continued expansion and innovation in the transcranial doppler market from 2025 to 2032.

Table of Contents

1. Transcranial Doppler Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Transcranial Doppler Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Transcranial Doppler Market Key Factors Analysis

  • 5.1. Transcranial Doppler Market Drivers
    • 5.1.1. Increasing incidence of traumatic brain injuries
    • 5.1.2. Rising prevalence of neurological disorders
    • 5.1.3. A growing number of sports-related injuries
  • 5.2. Transcranial Doppler Market Restraints and Challenges
    • 5.2.1. Stringent regulatory approvals
    • 5.2.2. Availability of alternative options in the market
  • 5.3. Transcranial Doppler Market Opportunities
    • 5.3.1. Integration with Artificial Intelligence (AI) and cloud platforms in transcranial doppler monitoring devices

6. Transcranial Doppler Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Transcranial Doppler Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Portable
    • 7.1.2. Stand-alone
    • 7.1.3. Wearable
  • 7.2. By Mode of Operation
    • 7.2.1. Manual
    • 7.2.2. Automated
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Ambulatory Surgical Centers
    • 7.3.3. Others
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.1.2. Canada Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.1.3. Mexico Transcranial Doppler Market Size in USD million (2022-2032)
    • 7.4.2. Europe
      • 7.4.2.1. France Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.2. Germany Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.3. United Kingdom Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.4. Italy Transcranial Doppler market size in USD million (2022-2032)
      • 7.4.2.5. Spain Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.2.6. Rest of Europe Transcranial Doppler Market Size in USD million (2022-2032)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.2. Japan Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.3. India Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.4. Australia Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.5. South Korea Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.3.6. Rest of Asia-Pacific Transcranial Doppler Market Size in USD million (2022-2032)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.4.2. Africa Transcranial Doppler Market Size in USD million (2022-2032)
      • 7.4.4.3. South America Transcranial Doppler Market Size in USD million (2022-2032)

8. Transcranial Doppler Market Company and Product Profiles

  • 8.1. Atys Medical
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Compumedics Limited
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. NeuraSignal, Inc.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Recorders & Medicare Systems Pvt Ltd (RMS)
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Rimed Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Shenzhen Delica Medical Equipment Co., Ltd.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Viasonix.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. NeuraSignal, Inc.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Konica Minolta Healthcare India Private Limited
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. GE HealthCare
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Koninklijke Philips N.V.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Mindray
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. FUJIFILM Sonosite, Inc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. Siemens Healthcare Private Limited
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. CANON MEDICAL SYSTEMS CORPORATION
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Transcranial Doppler Market in Global (2022-2032)
  • Table 3: Transcranial Doppler Market in Global by Product Type (2022-2032)
  • Table 4: Transcranial Doppler Market in Global by Mode of Operation (2022-2032)
  • Table 5: Transcranial Doppler Market in Global by End-User (2022-2032)
  • Table 6: Transcranial Doppler Market in Global by Geography (2022-2032)
  • Table 7: Transcranial Doppler Market in North America (2022-2032)
  • Table 8: Transcranial Doppler Market in the United States (2022-2032)
  • Table 9: Transcranial Doppler Market in Canada (2022-2032)
  • Table 10: Transcranial Doppler Market in Mexico (2022-2032)
  • Table 11: Transcranial Doppler Market in Europe (2022-2032)
  • Table 12: Transcranial Doppler Market in France (2022-2032)
  • Table 13: Transcranial Doppler Market in Germany (2022-2032)
  • Table 14: Transcranial Doppler Market in United Kingdom (2022-2032)
  • Table 15: Transcranial Doppler Market in Italy (2022-2032)
  • Table 16: Transcranial Doppler Market in Spain (2022-2032)
  • Table 17: Transcranial Doppler Market in Rest of Europe (2022-2032)
  • Table 18: Transcranial Doppler Market in Asia-Pacific (2022-2032)
  • Table 19: Transcranial Doppler Market in China (2022-2032)
  • Table 20: Transcranial Doppler Market in Japan (2022-2032)
  • Table 21: Transcranial Doppler Market in India (2022-2032)
  • Table 22: Transcranial Doppler Market in Australia (2022-2032)
  • Table 23: Transcranial Doppler Market in South Korea (2022-2032)
  • Table 24: Transcranial Doppler Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Transcranial Doppler Market in Rest of the World (2022-2032)
  • Table 26: Transcranial Doppler Market in the Middle East (2022-2032)
  • Table 27: Transcranial Doppler Market in Africa (2022-2032)
  • Table 28: Transcranial Doppler Market in South America (2022-2032)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Transcranial Doppler Market in Global (2022-2032)
  • Figure 3: Transcranial Doppler Market in Global by Product Type (2022-2032)
  • Figure 4: Transcranial Doppler Market in Global by Mode of Operation (2022-2032)
  • Figure 5: Transcranial Doppler Market in Global by End-User (2022-2032)
  • Figure 6: Transcranial Doppler Market in Global by Geography (2022-2032)
  • Figure 7: Transcranial Doppler Market in North America (2022-2032)
  • Figure 8: Transcranial Doppler Market in the United States (2022-2032)
  • Figure 9: Transcranial Doppler Market in Canada (2022-2032)
  • Figure 10: Transcranial Doppler Market in Mexico (2022-2032)
  • Figure 11: Transcranial Doppler Market in Europe (2022-2032)
  • Figure 12: Transcranial Doppler Market in France (2022-2032)
  • Figure 13: Transcranial Doppler Market in Germany (2022-2032)
  • Figure 14: Transcranial Doppler Market in United Kingdom (2022-2032)
  • Figure 15: Transcranial Doppler Market in Italy (2022-2032)
  • Figure 16: Transcranial Doppler Market in Spain (2022-2032)
  • Figure 17: Transcranial Doppler Market in Rest of Europe (2022-2032)
  • Figure 18: Transcranial Doppler Market in Asia-Pacific (2022-2032)
  • Figure 19: Transcranial Doppler Market in China (2022-2032)
  • Figure 20: Transcranial Doppler Market in Japan (2022-2032)
  • Figure 21: Transcranial Doppler Market in India (2022-2032)
  • Figure 22: Transcranial Doppler Market in Australia (2022-2032)
  • Figure 23: Transcranial Doppler Market in South Korea (2022-2032)
  • Figure 24: Transcranial Doppler Market in Rest of Asia-Pacific (2022-2032)
  • Figure 25: Transcranial Doppler Market in Rest of the World (2022-2032)
  • Figure 26: Transcranial Doppler Market in the Middle East (2022-2032)
  • Figure 27: Transcranial Doppler Market in Africa (2022-2032)
  • Figure 28: Transcranial Doppler Market in South America (2022-2032)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Marker Opportunities
  • Figure 32: PORTER'S Five Force Analysis